SMITH CHAS P & ASSOCIATES PA CPAS - Empyrean Bioscience Inc. Com ownership

Empyrean Bioscience Inc. Com's ticker is EMDG and the CUSIP is 29245E103. A total of 1 filers reported holding Empyrean Bioscience Inc. Com in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SMITH CHAS P & ASSOCIATES PA CPAS ownership history of Empyrean Bioscience Inc. Com
ValueSharesWeighting
Q2 2023$024,4500.0%0.00%
Q1 2023$024,4500.0%0.00%
Q4 2022$024,4500.0%0.00%
Q3 2022$024,4500.0%0.00%
Q2 2022$024,4500.0%0.00%
Q1 2022$024,4500.0%0.00%
Q4 2021$024,4500.0%0.00%
Q3 2021$024,4500.0%0.00%
Q2 2021$024,4500.0%0.00%
Q1 2021$024,4500.0%0.00%
Q4 2020$024,4500.0%0.00%
Q3 2020$024,4500.0%0.00%
Q2 2020$024,4500.0%0.00%
Q1 2020$024,4500.0%0.00%
Q4 2019$024,4500.0%0.00%
Q3 2019$024,4500.0%0.00%
Q2 2019$024,4500.00%
Other shareholders
Empyrean Bioscience Inc. Com shareholders Q2 2020
NameSharesValueWeighting ↓
SMITH CHAS P & ASSOCIATES PA CPAS 24,450$00.00%
Leelyn Smith, LLC 1,500$00.00%
View complete list of Empyrean Bioscience Inc. Com shareholders